glp-1 list of drugs What to know about the new era types of glp 1 drugs

Ishida, M

The complex pathophysiology and the metabolic risk factors shared between type 2 diabetes, obesity, CKD and cardiovascular disease have led to the concept of a cardiovascularkidneymetabolic (CKM) syndrome

Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study

Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease

The mechanisms underlying these effects involve the modulation of signaling pathways associated with cell growth, survival, and metabolism

Cree is a physician scientist, pediatric endocrinologist, and associate professor at the University of Colorado Anschutz and Childrens Hospital Colorado